KELSEY DENNING: Open Payments
NPI 1619401833 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 33 payments from 12 companies in 2025. Trend: 2023 $785 · 2024 $489 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 11 | $198 |
| MILLICENT US INC | 3 | $52 |
| Sumitomo Pharma America, Inc. | 3 | $49 |
| Radius Health, Inc. | 2 | $47 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $38 |
| Organon LLC | 2 | $37 |
| Exeltis, USA Inc. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Hologic Sales and Service, LLC | 1 | $19 |
| Sage Therapeutics, LLC | 1 | $19 |
Products named: Veozah, MYFEMBREE, NEXPLANON, INTRAROSA, SLYND, Lynkuet, APTIMA, ZURZUVAE.
Industry payments across NJ — which companies pay providers there.
